Symbiotic-GYN-18: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Advanced or Recurrent MMR-proficient Endometrial Cancer

NCT07578649 · clinicaltrials.gov ↗

PHASE3

Phase

NOT_YET_RECRUITING

Status

600

Enrollment

INDUSTRY

Sponsor class

Conditions

Endometrial Neoplasms
Endometrial Cancer

Interventions

BIOLOGICAL: PF-08634404
BIOLOGICAL: Pembrolizumab
DRUG: Standard of Care Chemotherapy

Sponsor

Pfizer

Collaborators

[object Object]